HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma.

AuthorsNorito Ishii, Takahiro Hamada, Hiroshi Koga, Ryosuke Sogame, Bungo Ohyama, Shunpei Fukuda, Yohei Natsuaki, Teruki Dainichi, Tadashi Karashima, Takekuni Nakama, Daisuke Tsuruta, Takashi Hashimoto
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2012 Jul-Aug Vol. 22 Issue 4 Pg. 547-9 ISSN: 1952-4013 [Electronic] France
PMID22548836 (Publication Type: Case Reports, Letter)
Chemical References
  • Autoantibodies
  • Desmoglein 3
  • Glucocorticoids
  • Membrane Proteins
  • Protein Precursors
  • envoplakin
  • Prednisolone
Topics
  • Administration, Oral
  • Aged
  • Autoantibodies (analysis)
  • Desmoglein 3 (immunology)
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Membrane Proteins (immunology)
  • Paraneoplastic Syndromes (immunology)
  • Pemphigus (complications, drug therapy, immunology)
  • Prednisolone (administration & dosage)
  • Protein Precursors (immunology)
  • Thymoma (complications, immunology)
  • Thymus Neoplasms (complications, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: